TELA BIO INC's ticker is TELA and the CUSIP is 872381108.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,684,336 | -21.0% | 2,835,542 | 0.0% | 0.48% | -7.3% |
Q2 2023 | $28,724,040 | -10.8% | 2,835,542 | -6.3% | 0.52% | -17.7% |
Q1 2023 | $32,213,047 | -7.5% | 3,027,542 | 0.0% | 0.63% | -5.1% |
Q4 2022 | $34,816,733 | +35.0% | 3,027,542 | 0.0% | 0.67% | +39.0% |
Q3 2022 | $25,795,000 | +21.5% | 3,027,542 | 0.0% | 0.48% | +24.4% |
Q2 2022 | $21,223,000 | -39.7% | 3,027,542 | 0.0% | 0.38% | -32.6% |
Q1 2022 | $35,210,000 | -9.1% | 3,027,542 | 0.0% | 0.57% | +14.7% |
Q4 2021 | $38,753,000 | -6.3% | 3,027,542 | 0.0% | 0.50% | +9.7% |
Q3 2021 | $41,356,000 | -15.2% | 3,027,542 | 0.0% | 0.45% | -7.9% |
Q2 2021 | $48,774,000 | +8.1% | 3,027,542 | 0.0% | 0.49% | +16.8% |
Q1 2021 | $45,110,000 | -0.9% | 3,027,542 | 0.0% | 0.42% | +6.0% |
Q4 2020 | $45,534,000 | -9.1% | 3,027,542 | 0.0% | 0.40% | -36.7% |
Q3 2020 | $50,076,000 | +27.6% | 3,027,542 | 0.0% | 0.63% | +13.9% |
Q2 2020 | $39,237,000 | +65.7% | 3,027,542 | 0.0% | 0.55% | +38.7% |
Q1 2020 | $23,675,000 | -39.6% | 3,027,542 | 0.0% | 0.40% | -28.9% |
Q4 2019 | $39,207,000 | – | 3,027,542 | – | 0.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 1,833,989 | $25,052,000 | 5.56% |
Opaleye Management Inc. | 443,199 | $6,054,000 | 1.13% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 113,000 | $1,544,000 | 0.56% |
Orbimed Advisors | 3,027,542 | $41,356,000 | 0.45% |
Parkman Healthcare Partners LLC | 100,000 | $1,366,000 | 0.35% |
RTW INVESTMENTS, LP | 1,391,619 | $19,010,000 | 0.29% |
SANDERS MORRIS HARRIS LLC | 107,168 | $1,464,000 | 0.27% |
COWEN AND COMPANY, LLC | 392,100 | $5,356,000 | 0.25% |
PURA VIDA INVESTMENTS, LLC | 580,515 | $7,930,000 | 0.24% |
Granite Point Capital Management, L.P. | 227,644 | $3,110,000 | 0.24% |